These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17631083)

  • 1. Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure.
    Ahmed A; Gambassi G; Weaver MT; Young JB; Wehrmacher WH; Rich MW
    Am J Cardiol; 2007 Jul; 100(2):280-4. PubMed ID: 17631083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial.
    Ahmed A; Pitt B; Rahimtoola SH; Waagstein F; White M; Love TE; Braunwald E
    Int J Cardiol; 2008 Jan; 123(2):138-46. PubMed ID: 17382417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations.
    Ahmed A
    J Gerontol A Biol Sci Med Sci; 2007 Mar; 62(3):323-9. PubMed ID: 17389731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.
    Ahmed A; Rich MW; Love TE; Lloyd-Jones DM; Aban IB; Colucci WS; Adams KF; Gheorghiade M
    Eur Heart J; 2006 Jan; 27(2):178-86. PubMed ID: 16339157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial.
    ; Ahmed A; Waagstein F; Pitt B; White M; Zannad F; Young JB; Rahimtoola SH
    Am J Cardiol; 2009 Jan; 103(1):82-7. PubMed ID: 19101235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical benefits of low serum digoxin concentrations in heart failure.
    Adams KF; Gheorghiade M; Uretsky BF; Patterson JH; Schwartz TA; Young JB
    J Am Coll Cardiol; 2002 Mar; 39(6):946-53. PubMed ID: 11897434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study.
    Miura T; Kojima R; Mizutani M; Shiga Y; Takatsu F; Suzuki Y
    Eur J Clin Pharmacol; 2001 Apr; 57(1):77-83. PubMed ID: 11372597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.
    Ahmed A; Rich MW; Fleg JL; Zile MR; Young JB; Kitzman DW; Love TE; Aronow WS; Adams KF; Gheorghiade M
    Circulation; 2006 Aug; 114(5):397-403. PubMed ID: 16864724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum digoxin concentration and outcomes in patients with heart failure.
    Rathore SS; Curtis JP; Wang Y; Bristow MR; Krumholz HM
    JAMA; 2003 Feb; 289(7):871-8. PubMed ID: 12588271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods.
    Ahmed A; Husain A; Love TE; Gambassi G; Dell'Italia LJ; Francis GS; Gheorghiade M; Allman RM; Meleth S; Bourge RC
    Eur Heart J; 2006 Jun; 27(12):1431-9. PubMed ID: 16709595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction.
    Ahmed A; Aban IB; Weaver MT; Aronow WS; Fleg JL
    Eur J Heart Fail; 2006 Jun; 8(4):409-19. PubMed ID: 16311070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial.
    Adams KF; Butler J; Patterson JH; Gattis Stough W; Bauman JL; van Veldhuisen DJ; Schwartz TA; Sabbah H; Mackowiak JI; Ventura HO; Ghali JK
    Eur J Heart Fail; 2016 Aug; 18(8):1072-81. PubMed ID: 27492641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of digoxin on mortality and morbidity in patients with heart failure.
    Digitalis Investigation Group
    N Engl J Med; 1997 Feb; 336(8):525-33. PubMed ID: 9036306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis.
    Adams KF; Patterson JH; Gattis WA; O'Connor CM; Lee CR; Schwartz TA; Gheorghiade M
    J Am Coll Cardiol; 2005 Aug; 46(3):497-504. PubMed ID: 16053964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure.
    Ahmed A; Young JB; Love TE; Levesque R; Pitt B
    Int J Cardiol; 2008 Apr; 125(2):246-53. PubMed ID: 17706809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Digoxin and angiotensin-converting enzyme inhibitors in the treatment of chronic congestive heart failure].
    Thery C
    Therapie; 1994; 49(3):211-8. PubMed ID: 7878586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.
    Gheorghiade M; Patel K; Filippatos G; Anker SD; van Veldhuisen DJ; Cleland JG; Metra M; Aban IB; Greene SJ; Adams KF; McMurray JJ; Ahmed A
    Eur J Heart Fail; 2013 May; 15(5):551-9. PubMed ID: 23355060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.